StockCIK 914475
NEUROCRINE BIOSCIENCES INC (NBIX): Insider Trades and Fund Holdings
In the past 12 months, NEUROCRINE BIOSCIENCES INC insiders reported 0 open-market purchases worth $0 and 3 sales worth $826K; 3 of the sales were reported as made under a 10b5-1 trading plan.
0Insider buys, 12 months
$0Bought by insiders, 12 months
$826KSold by insiders, 12 months
2Tracked funds holding
Recent insider trades
Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Sep 15, 2026.
| Filed | Insider | Type | Value |
|---|---|---|---|
| Sep 15 | Matt AbernethyCFO | ▼ SELL10b5-1 | $363K |
| Sep 15 | David W. BoyerChief Corp. Affairs Officer | ▼ SELL10b5-1 | $130K |
| Sep 10 | Eric BenevichChief Commercial Officer | ▼ SELL10b5-1 | $333K |
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings
Insiders who traded in the past year
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Matt Abernethy | CFO | 0 | $0 | 1 | $363K |
| David W. Boyer | Chief Corp. Affairs Officer | 0 | $0 | 1 | $130K |
| Eric Benevich | Chief Commercial Officer | 0 | $0 | 1 | $333K |
Tracked funds that report NBIX
From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.
| Fund | Shares | Value | Change |
|---|---|---|---|
| Renaissance Technologies | 2,335,897 | $393.7M | ▼ −3.4% |
| Bridgewater Associates | 205,677 | $34.7M | ▲ +38.8% |
Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings
Reading these numbers
Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →